Related Experiment Video
Updated: May 6, 2026
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Sclerostin deficient mice rapidly heal bone defects by activating β-catenin and increasing intramembranous
Meghan E McGee-Lawrence1, Zachary C Ryan, Lomeli R Carpio
1Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Mayo Clinic, 200 1st St., Southwest, Rochester, MN 55905, USA.
Abstract:
We investigated the influence of the osteocyte protein, sclerostin, on fracture healing by examining the dynamics and mechanisms of repair of single-cortex, stabilized femoral defects in sclerostin knockout (Sost(-/-); KO) and sclerostin wild-type (Sost(+/+); WT) mice. Fourteen days following generation of bone defects, Sost KO mice had significantly more bone in the healing defect than WT mice. The increase in regenerating bone was due to an increase in the thickness of trabecularized spicules, osteoblast numbers and surfaces within the defect. Enhanced healing of bone defects in Sost KO mice was associated with significantly more activated β-catenin expression than observed in WT mice. The findings were similar to those observed in Axin2(-/-) mice, in which β-catenin signaling is known to be enhanced to facilitate bone regeneration. Taken together, these data indicate that enhanced β-catenin signaling is present in Sost(-/-) mice that demonstrate accelerated healing of bone defects, suggesting that modulation of β-catenin signaling in bone could be used to promote fracture repair.
Insights
Removing sclerostin (Sost) protein accelerates fracture healing by increasing bone formation and osteoblast activity. This enhanced bone repair is linked to increased beta-catenin signaling, suggesting a new therapeutic target for bone regeneration.
Area of Science:
- Orthopedics
- Bone Biology
- Regenerative Medicine
Background:
- Sclerostin is an osteocyte-secreted protein that inhibits bone formation.
- Understanding sclerostin's role is crucial for developing strategies to enhance fracture healing.
Purpose of the Study:
- To investigate the effect of sclerostin deficiency on the healing of bone defects.
- To elucidate the mechanisms underlying sclerostin's influence on fracture repair.
Main Methods:
- Utilized sclerostin knockout (Sost(-/-)) and wild-type (Sost(+/+)) mice with stabilized femoral defects.
- Analyzed bone regeneration, osteoblast numbers, and beta-catenin signaling at 14 days post-defect creation.
Main Results:
- Sclerostin knockout mice exhibited significantly increased bone mass in healing defects compared to wild-type mice.
- Enhanced bone regeneration in Sost(-/-) mice was attributed to increased trabecular spicule thickness and osteoblast populations.
- Increased activated beta-catenin expression was observed in Sost(-/-) mice, correlating with accelerated healing.
Conclusions:
- Sclerostin deficiency promotes fracture healing through enhanced bone formation.
- Activated beta-catenin signaling is a key mechanism mediating accelerated bone repair in the absence of sclerostin.
- Modulating beta-catenin signaling presents a potential therapeutic approach for promoting fracture repair.
